$4.00
-0.09-2.2%
Last update: Nov 10, 9:27 AM
Vanda Pharmaceuticals Inc
VNDANASDAQ
The average analyst price target for Vanda Pharmaceuticals is $13.07, 226.8% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $7.50 to $20. The latest change came on Sep 23, 2026, when Oppenheimer initiated coverage of Vanda Pharmaceuticals with an Outperform rating and a $10 price target.
Price Target Range — 10 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
